Precision Biosciences (DTIL) Selling, General & Administrative (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 6.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.80 Mn |
| Dec 31, 2025 | 7.23 Mn |
| Sep 30, 2025 | 7.33 Mn |
| Jun 30, 2025 | 9.13 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Jun 30, 2024 | 8.53 Mn |
| Mar 31, 2024 | 8.43 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Sep 30, 2023 | 9.63 Mn |
| Jun 30, 2023 | 9.83 Mn |
| Mar 31, 2023 | 11.09 Mn |
| Dec 31, 2022 | 10.02 Mn |
| Sep 30, 2022 | 10.28 Mn |
| Jun 30, 2022 | 10.44 Mn |
| Mar 31, 2022 | 10.68 Mn |
| Dec 31, 2021 | 10.59 Mn |
| Sep 30, 2021 | 9.64 Mn |
| Jun 30, 2021 | 9.94 Mn |
| Mar 31, 2021 | 9.50 Mn |
| Dec 31, 2020 | 9.20 Mn |
| Sep 30, 2020 | 8.53 Mn |
| Jun 30, 2020 | 8.70 Mn |
| Mar 31, 2020 | 9.62 Mn |
| Dec 31, 2019 | 8.48 Mn |
| Sep 30, 2019 | 7.05 Mn |
| Jun 30, 2019 | 6.50 Mn |
| Mar 31, 2019 | 5.00 Mn |
| Dec 31, 2018 | 4.65 Mn |
| Sep 30, 2018 | 3.25 Mn |
| Jun 30, 2018 | 3.13 Mn |
| Mar 31, 2018 | 2.65 Mn |